The impact of multidisciplinary therapy in node-positive rectal cancer

Matthew Roos, Jan H. Wong, Sharmila Roy-Chowdhury, Sharon S. Lum, John W. Morgan, Kevork Kazanjian

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Multidisciplinary therapy (MDT) of node-positive rectal cancer is considered optimal. We performed a retrospective cohort study of node positive rectal cancer patients diagnosed between January 1, 1994 and December 31, 2003 in Region 5 of the California Cancer Registry to determine the impact of MDTon disease specific survival (DSS). During the study period, 398 patients with stage III rectal cancer were identified. Only 251 patients (63.1%) received radiation (XRT). Patients receiving XRT had significantly improved survival when compared with those who did not (5 year DSS 55% with XRT vs 36% without XRT, median follow-up 43 months, P <0.001). There was no statistically significant difference in Tstage (P = 0.41), the number of N1 patients (P = 0.45), or the number of positive nodes harvested (mean 11.5 w/o XRT vs 12.8 w/XRT, P = 0.37) between patients receiving XRT and those who did not. Patients receiving XRT were far more likely to receive systemic chemotherapy (83% vs 27%, P <0.0001). Multidisciplinary therapy of node-positive rectal cancer is associated with improved DSS. However, substantial numbers of node positive rectal cancer patients are not receiving MDT. Greater efforts are needed to implement consistent multidisciplinary algorithms into rectal cancer management.

Original languageEnglish (US)
Pages (from-to)1163-1166
Number of pages4
JournalAmerican Surgeon
Volume76
Issue number10
StatePublished - Oct 2010
Externally publishedYes

Fingerprint

Rectal Neoplasms
Survival
Therapeutics
Registries
Cohort Studies
Retrospective Studies
Radiation
Drug Therapy
Neoplasms

ASJC Scopus subject areas

  • Surgery

Cite this

Roos, M., Wong, J. H., Roy-Chowdhury, S., Lum, S. S., Morgan, J. W., & Kazanjian, K. (2010). The impact of multidisciplinary therapy in node-positive rectal cancer. American Surgeon, 76(10), 1163-1166.

The impact of multidisciplinary therapy in node-positive rectal cancer. / Roos, Matthew; Wong, Jan H.; Roy-Chowdhury, Sharmila; Lum, Sharon S.; Morgan, John W.; Kazanjian, Kevork.

In: American Surgeon, Vol. 76, No. 10, 10.2010, p. 1163-1166.

Research output: Contribution to journalArticle

Roos, M, Wong, JH, Roy-Chowdhury, S, Lum, SS, Morgan, JW & Kazanjian, K 2010, 'The impact of multidisciplinary therapy in node-positive rectal cancer', American Surgeon, vol. 76, no. 10, pp. 1163-1166.
Roos M, Wong JH, Roy-Chowdhury S, Lum SS, Morgan JW, Kazanjian K. The impact of multidisciplinary therapy in node-positive rectal cancer. American Surgeon. 2010 Oct;76(10):1163-1166.
Roos, Matthew ; Wong, Jan H. ; Roy-Chowdhury, Sharmila ; Lum, Sharon S. ; Morgan, John W. ; Kazanjian, Kevork. / The impact of multidisciplinary therapy in node-positive rectal cancer. In: American Surgeon. 2010 ; Vol. 76, No. 10. pp. 1163-1166.
@article{db39f78be8964f8ba0801cb37b2b598c,
title = "The impact of multidisciplinary therapy in node-positive rectal cancer",
abstract = "Multidisciplinary therapy (MDT) of node-positive rectal cancer is considered optimal. We performed a retrospective cohort study of node positive rectal cancer patients diagnosed between January 1, 1994 and December 31, 2003 in Region 5 of the California Cancer Registry to determine the impact of MDTon disease specific survival (DSS). During the study period, 398 patients with stage III rectal cancer were identified. Only 251 patients (63.1{\%}) received radiation (XRT). Patients receiving XRT had significantly improved survival when compared with those who did not (5 year DSS 55{\%} with XRT vs 36{\%} without XRT, median follow-up 43 months, P <0.001). There was no statistically significant difference in Tstage (P = 0.41), the number of N1 patients (P = 0.45), or the number of positive nodes harvested (mean 11.5 w/o XRT vs 12.8 w/XRT, P = 0.37) between patients receiving XRT and those who did not. Patients receiving XRT were far more likely to receive systemic chemotherapy (83{\%} vs 27{\%}, P <0.0001). Multidisciplinary therapy of node-positive rectal cancer is associated with improved DSS. However, substantial numbers of node positive rectal cancer patients are not receiving MDT. Greater efforts are needed to implement consistent multidisciplinary algorithms into rectal cancer management.",
author = "Matthew Roos and Wong, {Jan H.} and Sharmila Roy-Chowdhury and Lum, {Sharon S.} and Morgan, {John W.} and Kevork Kazanjian",
year = "2010",
month = "10",
language = "English (US)",
volume = "76",
pages = "1163--1166",
journal = "American Surgeon",
issn = "0003-1348",
publisher = "Southeastern Surgical Congress",
number = "10",

}

TY - JOUR

T1 - The impact of multidisciplinary therapy in node-positive rectal cancer

AU - Roos, Matthew

AU - Wong, Jan H.

AU - Roy-Chowdhury, Sharmila

AU - Lum, Sharon S.

AU - Morgan, John W.

AU - Kazanjian, Kevork

PY - 2010/10

Y1 - 2010/10

N2 - Multidisciplinary therapy (MDT) of node-positive rectal cancer is considered optimal. We performed a retrospective cohort study of node positive rectal cancer patients diagnosed between January 1, 1994 and December 31, 2003 in Region 5 of the California Cancer Registry to determine the impact of MDTon disease specific survival (DSS). During the study period, 398 patients with stage III rectal cancer were identified. Only 251 patients (63.1%) received radiation (XRT). Patients receiving XRT had significantly improved survival when compared with those who did not (5 year DSS 55% with XRT vs 36% without XRT, median follow-up 43 months, P <0.001). There was no statistically significant difference in Tstage (P = 0.41), the number of N1 patients (P = 0.45), or the number of positive nodes harvested (mean 11.5 w/o XRT vs 12.8 w/XRT, P = 0.37) between patients receiving XRT and those who did not. Patients receiving XRT were far more likely to receive systemic chemotherapy (83% vs 27%, P <0.0001). Multidisciplinary therapy of node-positive rectal cancer is associated with improved DSS. However, substantial numbers of node positive rectal cancer patients are not receiving MDT. Greater efforts are needed to implement consistent multidisciplinary algorithms into rectal cancer management.

AB - Multidisciplinary therapy (MDT) of node-positive rectal cancer is considered optimal. We performed a retrospective cohort study of node positive rectal cancer patients diagnosed between January 1, 1994 and December 31, 2003 in Region 5 of the California Cancer Registry to determine the impact of MDTon disease specific survival (DSS). During the study period, 398 patients with stage III rectal cancer were identified. Only 251 patients (63.1%) received radiation (XRT). Patients receiving XRT had significantly improved survival when compared with those who did not (5 year DSS 55% with XRT vs 36% without XRT, median follow-up 43 months, P <0.001). There was no statistically significant difference in Tstage (P = 0.41), the number of N1 patients (P = 0.45), or the number of positive nodes harvested (mean 11.5 w/o XRT vs 12.8 w/XRT, P = 0.37) between patients receiving XRT and those who did not. Patients receiving XRT were far more likely to receive systemic chemotherapy (83% vs 27%, P <0.0001). Multidisciplinary therapy of node-positive rectal cancer is associated with improved DSS. However, substantial numbers of node positive rectal cancer patients are not receiving MDT. Greater efforts are needed to implement consistent multidisciplinary algorithms into rectal cancer management.

UR - http://www.scopus.com/inward/record.url?scp=78651356137&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78651356137&partnerID=8YFLogxK

M3 - Article

C2 - 21105635

AN - SCOPUS:78651356137

VL - 76

SP - 1163

EP - 1166

JO - American Surgeon

JF - American Surgeon

SN - 0003-1348

IS - 10

ER -